Mesenchymal Cell News Volume 4.37 | Sep 18 2012

    0
    24

    Mesenchymal Cell News 4.37 September 18, 2012

         In this issue: Publications | ReviewsIndustry News | Policy News | Events | Jobs 
    Cell Therapy News on Facebook  Mesenchymal Cell News on Twitter

    TOP STORY

    Hedgehog-Responsive Mesenchymal Clusters Direct Patterning and Emergence of Intestinal Villi
    Researchers analyzed the cell biology of villus formation and examined the role of paracrine epithelial Hedgehog (Hh) signals in this process. They found that, before villus emergence, tight clusters of Hh-responsive mesenchymal cells form just beneath the epithelium. [Proc Natl Acad Sci USA] Abstract

    Contract Assay Services: Expand, Differentiate and Characterize Mesenchymal Stem Cells With Our Customizable In Vitro Assays. Download our FREE Brochure.

    PUBLICATIONS (Ranked by impact factor of the journal)

    High-Efficiency Matrix Modulus-Induced Cardiac Differentiation of Human Mesenchymal Stem Cells Inside a Thermosensitive Hydrogel
    The authors have developed a thermosensitive and injectable hydrogel suitable for the delivery of cells into the heart, and found that the appropriate gel modulus can differentiate mesenchymal stem cells into cardiac cells with high efficiency. [Acta Biomater] Abstract

    Dynamic MicroRNA Profiles of Hepatic Differentiated Human Umbilical Cord Lining-Derived Mesenchymal Stem Cells
    Researchers aimed to identify microRNAs involved in the hepatic differentiation of human umbilical cord lining-derived mesenchymal stem cells (hUC-MSC). After isolating hUC-MSCs, they induced hepatocyte formation in vitro with growth factors. After 26 days of induction, hUC-MSCs could express hepatocyte-specific genes, synthesize urea and glycogen and uptake low-density lipoprotein. [PLoS One] Full Article

    Aging Effect on Neurotrophic Activity of Human Mesenchymal Stem Cells

    Researchers isolated human mesenchymal stem cells (MSCs) from bone marrow of young and old donors and analyzed their capacity to differentiate and promote neurite outgrowth from dorsal root ganglia neurons. Treatment of MSCs with growth factors induced protein expression of the glial cell marker S100 in cultures from young but not old donors. [PLoS One] Full Article

    The Influence of Polymer Scaffolds on Cellular Behavior of Bone Marrow Derived Human Mesenchymal Stem Cells
    The interaction of mesenchymal stem cells (MSCs) with biomaterials is of great importance for cell proliferation, differentiation and function, and can be strongly influenced by numerous factors, such as the chemical nature and the mechanical properties of the material surface. Researchers investigated the interaction of bone marrow derived human MSCs with different amorphous and transparent polymers namely polystyrene, polycarbonate, poly(ether imide), polyetherurethane and poly(styrene-co-acrylonitrile). [Clin Hemorheol Microcirc] Abstract   

    Intraglandular Transplantation of Bone Marrow-Derived Clonal Mesenchymal Stem Cells for Amelioration of Post-Irradiation Salivary Gland Damage
    External irradiation in head and neck cancers may induce irreversible hyposalivation and consequent xerostomia, stemming from radiation damage to salivary glands (SGs). As cell-based therapy has been reported to be able to repair or restore damaged SG tissues, scientists attempted to determine whether bone marrow-derived clonal mesenchymal stem cells can ameliorate irradiation-induced salivary gland damage via a murine model. [Oral Oncol] Abstract

    Effects of Secretome Obtained from Normoxia-Preconditioned Human Mesenchymal Stem Cells in Traumatic Brain Injury Rats
    Results demonstrated that intravenous injection of secretome from normoxia-preconditioned human mesenchymal stem cells may ameliorate traumatic brain injury induced by fluid percussion injury in rats by reducing neuronal cell loss and apoptosis and promoting vascular epithelial growth factor production, resulting in functional outcome improvement. [Trauma Acute Care Surg] Abstract

    Co-Culture with Sertoli Cells Promotes Proliferation and Migration of Umbilical Cord Mesenchymal Stem Cells
    Researchers hypothesized that co-culture of human umbilical cord mesenchymal stem cells (UCMSCs) with Sertoli cells may promote proliferation and migration of UCMSCs. To examine this, they isolated UCMSCs from human cords and Sertoli cells from mouse testes, and co-cultured them using a Transwell system. They found that UCMSCs exhibited strong proliferation ability and potential to differentiate to other cell lineages such as osteocytes and adipocytes. [Biochem Biophys Res Commun] Abstract

    Establishment of Adipose-Derived Mesenchymal Stem Cell Lines from a p53-Knockout Mouse
    Researchers established several adipose-derived mesenchymal stem cell (MSC) clonal cell lines that maintain the tissue-specific markers and characteristics of the developmental phase. These clonal cell lines will serve as important tools to study the mechanism of differentiation of MSCs. [Biochem Biophys Res Commun] Abstract

    Fibroblast Growth Factor 2 Enhances the Kinetics of Mesenchymal Stem Cell Chondrogenesis
    To evaluate changes over time, researchers assessed chondrogenesis of human mesenchymal stem cells at early and late time points during pellet culture using real-time PCR, measurement of glycosaminoglycan accumulation, and histology. Marked enhancement of chondrogenesis was seen early compared to controls. However, the differences from controls in gene expression dramatically diminished over time. [Biochem Biophys Res Commun] Abstract

    Do Your Colleagues Know What They Are Missing? Share This Newsletter Now.

    REVIEWS

    Adipose Tissue-Derived Mesenchymal Stem Cells: A Fat Chance of Curing Kidney Disease?
    Mesenchymal stem cells (MSCs) are known for their anti-inflammatory properties and immune modulation. This review discusses whether demonstration that the phenotype and immunosuppressive ability of adipose tissue-derived MSCs are not affected by human kidney disease or uremic serum might have clinical significance if autologous adipose tissue-derived MSCs can be tested to prove their long-term safety and efficacy in treating kidney disease. [Kidney Int] Abstract

    Enter Our Contest 
    Mesenchymal Cell News is giving away a free registration for the 2012 World Stem Cell Summit in West Palm Beach! Chart the future of stem cell science and regenerative medicine at the largest interdisciplinary stem cell conference. Click here to enter.

    INDUSTRY NEWS

    $8.7 Million Awarded to Stem Cell Researchers in Clinical & Basic Biology Grants from the State Stem Cell Agency
    Nelson’s Early Translational award and the two Basic Biology IV grants, totaling $8.7 million, continue efforts by the California Institute of Regenerative Medicine to support research designed to take stem cell science from the laboratory to the clinic. [Eli and Edythe Broad Stem Cell Research Center at UCLA] Press Release

    Multicenter Investigator-Sponsored Cell Therapy Study for Peripheral Artery Disease Approved in Japan
    Cytori Therapeutics announced that a 40-patient, multi-center investigator-sponsored and funded clinical study in Japan using the Celution® System has been approved under the Ministry of Health, Labor and Welfare Guidelines on Clinical Research Using Human Stem Cells. The study will investigate the use of patients’ own adipose-derived stem and regenerative cells processed by the Celution® System for peripheral artery disease or arteriosclerosis obliterans. [Cytori Therapeutics, Inc.] Press Release

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS

    NEW International Conference on Emerging Cell Therapies
    October 1-2, 2012
    Chicago, United States


    Visit
    our events page to see a complete list of events in the mesenchymal cell community.

    JOB OPPORTUNITIES

    Quality Control Operations Coordinator (STEMCELL Technologies, Inc.)

    Research Technologist – Media Development (STEMCELL Technologies, Inc.)

    Research Technologist – Research and Development (STEMCELL Technologies, Inc.)

    Scientific Communications & Publishing Coordinator (STEMCELL Technologies, Inc.)

    Postdoctoral Position – Molecular Cell Biology (Weizmann Institute of Science)

    Research Associate – Quality Assurance (University of California)

    Postdoctoral Position – DNA Repair and Genomic Instability in Mesenchymal Stromal/Stem Cells (University of Rennes 1)

    Recruit Top Talent: Reach more than 55,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Mesenchymal Cell News: Archives | Events | Contact Us

    Suite 201 – 375 West Fifth Avenue
    Vancouver, BC, V5Y 1J6, Canada